Dr. Naiem Issa discusses his article published in JCAD January 2025, titled “Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series.”
Reference:
Dr. Graber discusses her article published in JCAD January 2025, titled “Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl...
PLAY
Dr. Naiem Issa discusses his article published in JCAD January 2025, titled “Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis:...
PLAY
Dr. Nada Elbuluk discusses her article published in JCAD January 2025, titled “Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional...
PLAY
Tina Bhutani, MD, discusses a new article published in the October 2024 issue of JCAD that describes patient-reported symptoms and treatment satisfaction in patients with...
PLAY
Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic...
PLAY
James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology
James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive...
PLAY
Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients...
PLAY
Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe...
PLAY
Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach...
PLAY